Impaired Angiogenesis Following Hindlimb Ischemia in Type 2 Diabetes Mellitus Differential Regulation of Vascular Endothelial Growth Factor Receptor 1 and Soluble VEGFR-1
نویسندگان
چکیده
Deficient angiogenesis following ischemia may contribute to worse outcomes of peripheral arterial disease in patients with diabetes mellitus (DM). Vascular endothelial growth factor (VEGF) and its receptors promote angiogenesis. We hypothesized that in peripheral arterial disease, maladaptive changes in VEGF ligand/receptor expression could account for impaired angiogenesis in DM. Skeletal muscle from diet-induced, type 2 diabetic (DM) and age-matched normal chow (NC)-fed mice was collected at baseline and 3 and 10 days after hindlimb ischemia and analyzed for expression of VEGF (n 10 per group), full-length VEGF receptor (VEGFR)-1, soluble VEGFR-1, and markers of downstream VEGF signaling (n 20 per group) using ELISA, RT-PCR, and Western blots. In the absence of ischemia, DM mice had increased VEGF (NC versus DM: 26.6 2.6 versus 53.5 8.8 pg/mg protein; P 0.05), decreased soluble and membrane-bound VEGFR-1 (NC versus DM: 1.44 0.30 versus 0.85 0.08 and 1.03 0.10 versus 0.72 0.10, respectively; P 0.05). decreased phospho-AKT/AKT and phospho–endothelial NO synthase/endothelial NO synthase (NC versus DM: 0.76 0.2 versus 0.38 0.1 and 0.36 0.06 versus 0.25 0.04, respectively; P 0.05), and no change in VEGFR-2. Following ischemia, both DM and NC had comparable increases in VEGF-A. VEGFR-1 and soluble VEGFR-1 expression increased in both groups, but the fold increase was significantly greater in DM. These data demonstrate that soluble VEGFR-1, an angiogenesis inhibitor, is regulated in skeletal muscle by type 2 DM and ischemia. In the absence of ischemia, despite reductions in both soluble VEGFR-1 and VEGFR-1, VEGF ligand signaling is lower in DM compared with controls. Following ischemia, maladaptive upregulation of these receptors further reduces the capacity of VEGF to induce an angiogenic response, which may provide a novel target for therapy. (Circ Res. 2007;101:0-0.)
منابع مشابه
Impaired Angiogenesis After Hindlimb Ischemia in Type 2 Diabetes Mellitus
Deficient angiogenesis after ischemia may contribute to worse outcomes of peripheral arterial disease in patients with diabetes mellitus (DM). Vascular endothelial growth factor (VEGF) and its receptors promote angiogenesis. We hypothesized that in peripheral arterial disease, maladaptive changes in VEGF ligand/receptor expression could account for impaired angiogenesis in DM. Skeletal muscle f...
متن کاملPan-PPAR Agonist, Bezafibrate, Restores Angiogenesis in Hindlimb Ischemia in Normal and Diabetic Rats
Introduction. The aim of this study was to investigate the effect of bezafibrate as a pan-PPAR agonist on angiogenesis and serum nitrite, the main metabolite of nitric oxide (NO), vascular endothelial growth factor (VEGF) and VEGF receptor-2 (VEGFR-2) concentrations in hindlimb ischemia model of normal and type I diabetic rats. Methods. 28 male Wistar rats were divided into control and diabetic...
متن کاملRosiglitazone enhances neovascularization in diabetic rat ischemic hindlimb model.
BACKGROUND There is increasing evidence that peroxisome proliferator-activated receptors (PPARs) may be involved in the regulation of angiogenesis. In this study, we examined whether rosiglitazone, a PPARγ agonist, can restore angiogenesis in a rat hindlimb ischemia model of diabetes. METHODS Male wistar rats were divided into four groups (n=6 each): control, diabetic and control and diabetic...
متن کاملFine-tuning the angiogenic response to vascular endothelial growth factor.
Vascular endothelial growth factor (VEGF) is an important mediator of vascular development and postnatal angiogenesis.1,2 Homozygous deletion of VEGF gene leads to impaired vascular formation and early embryonic lethality.3 Interestingly, deletion of just one VEGF allele is sufficient to produce similar vascular abnormalities,3,4 suggesting that the strength and integrity of the VEGF signaling ...
متن کاملCoordinated Activation of VEGF/VEGFR-2 and PPARδ Pathways by a Multi-Component Chinese Medicine DHI Accelerated Recovery from Peripheral Arterial Disease in Type 2 Diabetic Mice
Diabetic mellitus (DM) patients are at an increased risk of developing peripheral arterial disease (PAD). Danhong injection (DHI) is a Chinese patent medicine widely used for several cardiovascular indications but the mechanism of action is not well-understood. We investigated the therapeutic potential of DHI on experimental PAD in mice with chemically induced as well as genetic (KKAy) type 2 D...
متن کامل